| Nome |
# |
|
Fathoming the kynurenine pathway in migraine: why understanding the enzymatic cascades is still critically important, file e3835311-57d0-15e8-e053-a505fe0a3de9
|
338
|
|
Cardiovascular efficacy and safety of bococizumab in high-risk patients, file e383531b-fccf-15e8-e053-a505fe0a3de9
|
251
|
|
Altered kynurenine pathway metabolites in serum of chronic migraine patients, file e3835314-ca62-15e8-e053-a505fe0a3de9
|
121
|
|
Altered serum levels of kynurenine metabolites in patients affected by cluster headache, file e3835314-c2b8-15e8-e053-a505fe0a3de9
|
110
|
|
A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache. a real-world experience, file e3835314-c689-15e8-e053-a505fe0a3de9
|
110
|
|
Eletriptan in the management of acute migraine. An update on the evidence for efficacy, safety, and consistent response, file e3835315-c3b7-15e8-e053-a505fe0a3de9
|
110
|
|
Factors associated with costs of hospitalization of severely mentally Ill patients, file e383531a-55cc-15e8-e053-a505fe0a3de9
|
110
|
|
OnabotulinumtoxinA 155 U in medication overuse headache. a two years prospective study, file e3835314-c180-15e8-e053-a505fe0a3de9
|
100
|
|
Impact of migraine on fibromyalgia symptoms, file e3835314-cbed-15e8-e053-a505fe0a3de9
|
89
|
|
O066. Kynurenine pathway metabolites in cluster headache, file e383531e-ac5a-15e8-e053-a505fe0a3de9
|
88
|
|
Persistent post-traumatic headache and migraine: Pre-clinical comparisons, file e3835325-b196-15e8-e053-a505fe0a3de9
|
63
|
|
Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors, file 48490665-0bfc-4fa7-807a-9c0727da2b0e
|
56
|
|
The Italian version of the 92-item Prodromal Questionnaire: Concurrent validity with the SIPS and factor analysis in a sample of 258 outpatients aged 11-36years., file e3835316-78ce-15e8-e053-a505fe0a3de9
|
52
|
|
Xanthurenic Acid Activates mGlu2/3 metabotropic glutamate receptors and is a potential trait marker for schizophrenia, file e3835317-e731-15e8-e053-a505fe0a3de9
|
48
|
|
School refusal behavior. role of personality styles, social functioning, and psychiatric symptoms in a sample of adolescent help-seekers, file 0b13687f-1f19-428b-9328-a11d86f1c844
|
18
|
|
Efficacy of the “cooperative assessment” diagnostic procedure to early improve acute symptoms in a sample of adolescents with anxiety and mood disorders, file e3835316-e083-15e8-e053-a505fe0a3de9
|
13
|
|
Skin Rash Occurring with Olanzapine Pamoate, but not with Oral Olanzapine, in a Male with Juvenile Idiopathic Arthritis, file e3835311-ceb5-15e8-e053-a505fe0a3de9
|
9
|
|
Temperament and Character in Ultra-High Risk for Psychosis (UHR) compared to non-UHR helpseeking adolescents, file e383531d-b4a3-15e8-e053-a505fe0a3de9
|
8
|
|
Choosing the safest acute therapy during chronic migraine prophylactic treatment. pharmacokinetic and pharmacodynamic considerations, file e3835314-c611-15e8-e053-a505fe0a3de9
|
7
|
|
Effects of escitalopram on serum BDNF levels in elderly patients with depression: a preliminary report., file e3835313-005c-15e8-e053-a505fe0a3de9
|
6
|
|
Chronic migraine treatment. from OnabotulinumtoxinA onwards, file e383531b-8e07-15e8-e053-a505fe0a3de9
|
5
|
|
Relationship between the Rorschach Perceptual Thinking Index (PTI) and the Structured Interview for Prodromal Symptoms (SIPS) in a sample of helpseeker adolescents, file e383531d-a41b-15e8-e053-a505fe0a3de9
|
5
|
|
Acute, transitional and long-term cluster headache treatment. pharmacokinetic issues, file e383531e-8dc7-15e8-e053-a505fe0a3de9
|
5
|
|
EFFICACY OF THE COOPERATIVE ASSESSMENT METHOD (COOPAS) TO IMPROVE THE PSYCHIATRIC CARE OF HELP-SEEKING ADOLESCENTS, file e3835324-270c-15e8-e053-a505fe0a3de9
|
5
|
|
null, file e3835312-ac9c-15e8-e053-a505fe0a3de9
|
4
|
|
Validation of the Italian version of interpersonal sensitivity measure (IPSM) in adolescents and young adults, file e3835314-c621-15e8-e053-a505fe0a3de9
|
4
|
|
A critical evaluation on MOH current treatments, file e3835318-d8d1-15e8-e053-a505fe0a3de9
|
4
|
|
Lasmiditan for the treatment of migraine, file e383531c-4500-15e8-e053-a505fe0a3de9
|
4
|
|
Atogepant. Calcitonin gene-related peptide (CGRP) receptor antagonist, Preventive treatment of migraine, file e3835325-a538-15e8-e053-a505fe0a3de9
|
4
|
|
Psychotropic Drugs Levels in Seminal Fluid: A New Therapeutic Drug Monitoring Analysis?, file b8b33bad-3a14-4c97-8459-ad28cb9a3619
|
3
|
|
Electroconvulsive therapy improves clinical manifestations of treatment-resistant depression without changing serum BDNF levels, file e3835312-cbc5-15e8-e053-a505fe0a3de9
|
3
|
|
Interpersonal sensitivity and functioning impairment in youth at ultra-high risk for psychosis, file e3835312-fa2f-15e8-e053-a505fe0a3de9
|
3
|
|
Executive functions in obsessive–compulsive disorder. An activation likelihood estimate meta-analysis of fMRI studies, file e3835314-117f-15e8-e053-a505fe0a3de9
|
3
|
|
Rimegepant. calcitonin gene-related peptide (CGRP) receptor antagonist, treatment of migraine, file e3835323-5675-15e8-e053-a505fe0a3de9
|
3
|
|
The Trace Kynurenine, Cinnabarinic Acid, Displays Potent Antipsychotic-Like Activity in Mice and Its Levels Are Reduced in the Prefrontal Cortex of Individuals Affected by Schizophrenia, file e3835327-e7d4-15e8-e053-a505fe0a3de9
|
3
|
|
Relationship between the rorschach perceptual thinking Index (pti) and the positive and negative syndrome scale (panss) in psychotic patients: a validity study, file e3835311-5788-15e8-e053-a505fe0a3de9
|
2
|
|
The presence of depressive symptoms in comorbidity with Alzheimer's disease does not influence changes in serum brain-derived neurotrophic factor levels in older patients, file e3835312-5e15-15e8-e053-a505fe0a3de9
|
2
|
|
Features preceding diagnosis of bipolar versus major depressive disorders, file e3835312-d17b-15e8-e053-a505fe0a3de9
|
2
|
|
NeuroEndocrine- immunology in orthogeriatric patients: preliminary report on the acute modification of urinanry cortisol and serum BDNF levels in Alzheimer’s disease after osteoporotic hip fracture, file e3835313-2b57-15e8-e053-a505fe0a3de9
|
2
|
|
Headache. Cluster headache treatment-RCTs versus real-world evidence, file e3835315-c2dd-15e8-e053-a505fe0a3de9
|
2
|
|
Fathoming the kynurenine pathway in migraine: why understanding the enzymatic cascades is still critically important, file e3835319-b3ca-15e8-e053-a505fe0a3de9
|
2
|
|
Systematic review of clozapine cardiotoxicity, file e383531d-4077-15e8-e053-a505fe0a3de9
|
2
|
|
Depressive symptoms, temperament/character, and attention deficit/hyperactivity disorder traits in medical students seeking counseling, file e383531d-dee1-15e8-e053-a505fe0a3de9
|
2
|
|
Psychiatric comorbidity in migraine and chronic headache, file e383531e-bb1b-15e8-e053-a505fe0a3de9
|
2
|
|
Psychiatric comorbidity in migraine and chronic headache, file e383531e-d66a-15e8-e053-a505fe0a3de9
|
2
|
|
How do you choose the appropriate migraine pharmacotherapy for an elderly person?, file e3835323-5dca-15e8-e053-a505fe0a3de9
|
2
|
|
Sudden Death Associated with Complex Treatment of Acute Mania: Case Report and Toxicological Findings, file e3835324-1cbb-15e8-e053-a505fe0a3de9
|
2
|
|
Increased kynurenine-to-tryptophan ratio in the serum of patients infected with SARS-CoV2: An observational cohort study, file e383532c-ccb4-15e8-e053-a505fe0a3de9
|
2
|
|
Neurocognition in schizophrenia: from prodrome to multi-episode illness., file e3835312-d040-15e8-e053-a505fe0a3de9
|
1
|
|
Increased serum Dickkopf-1 levels in drug-abusing psychotic patients, file e3835312-d37b-15e8-e053-a505fe0a3de9
|
1
|
|
La terapia farmacologica della malattia di Alzheimer, file e3835313-2dd2-15e8-e053-a505fe0a3de9
|
1
|
|
null, file e3835315-4434-15e8-e053-a505fe0a3de9
|
1
|
|
LC-MS/MS simultaneous analysis of allopregnanolone; epiallopregnanolone; pregnanolone; dehydroepiandrosterone and dehydroepiandrosterone 3-sulfate in human plasma, file e383531e-de77-15e8-e053-a505fe0a3de9
|
1
|
|
Anti-CGRP monoclonal antibodies in migraine. current perspectives, file e383531f-b20b-15e8-e053-a505fe0a3de9
|
1
|
|
Fremanezumab for the preventive treatment of migraine in adults, file e3835323-1c35-15e8-e053-a505fe0a3de9
|
1
|
|
Serum xanthurenic acid levels. reduced in subjects at ultra high risk for psychosis, file e3835323-5eb1-15e8-e053-a505fe0a3de9
|
1
|
|
Impairment in Social Functioning differentiates youth meeting ultra-high risk for psychosis criteria from other mental health help-seekers. A validation of the Italian version of the Global Functioning: Social and Global Functioning: Role scales, file e3835323-5eb5-15e8-e053-a505fe0a3de9
|
1
|
|
Pharmacogenetic considerations for migraine therapies, file e3835323-5f81-15e8-e053-a505fe0a3de9
|
1
|
|
Profiling lasmiditan as a treatment option for migraine, file e3835324-1cbd-15e8-e053-a505fe0a3de9
|
1
|
|
Antipsychotic treatment and the Rorschach Perceptual Thinking Index (PTI) in psychotic disorder patients: Effects of treatment, file e3835324-88c2-15e8-e053-a505fe0a3de9
|
1
|
|
Ubrogepant for the treatment of migraine, file e3835325-ed43-15e8-e053-a505fe0a3de9
|
1
|
|
Tryptophan and kynurenine metabolites: Are they related to depression?, file e3835327-2bda-15e8-e053-a505fe0a3de9
|
1
|
|
Polyamines serum levels in episodic and chronic migraine, file e383532a-6997-15e8-e053-a505fe0a3de9
|
1
|
|
Unmet needs for migraine, file e383532d-43e3-15e8-e053-a505fe0a3de9
|
1
|
|
Cluster Headache is Still Lurking in the Shadows, file e383532d-43e5-15e8-e053-a505fe0a3de9
|
1
|
| Totale |
1.808 |